CXCL12 and hepatocellular carcinoma: In addition to the elevated number of circulating cells with E3 in LC patients with HCC than in LC patients without HCC, another interesting finding in the present study is the substantial increase in plasma level of SDF-1α in LC patients with HCC compared to that in those LC patients without HCC and healthy subjects.